ATE185797T1 - Stilben-derivate verwendbar als cyclooxygenase-2 hemmer - Google Patents
Stilben-derivate verwendbar als cyclooxygenase-2 hemmerInfo
- Publication number
- ATE185797T1 ATE185797T1 AT95944787T AT95944787T ATE185797T1 AT E185797 T1 ATE185797 T1 AT E185797T1 AT 95944787 T AT95944787 T AT 95944787T AT 95944787 T AT95944787 T AT 95944787T AT E185797 T1 ATE185797 T1 AT E185797T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclooxygenase
- pct
- inhibitors
- derivatives usable
- sec
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- C07F9/304—Aromatic acids (P-C aromatic linkage)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- C07F9/36—Amides thereof
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33017294A | 1994-10-27 | 1994-10-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE185797T1 true ATE185797T1 (de) | 1999-11-15 |
Family
ID=23288609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95944787T ATE185797T1 (de) | 1994-10-27 | 1995-10-24 | Stilben-derivate verwendbar als cyclooxygenase-2 hemmer |
Country Status (9)
Country | Link |
---|---|
US (1) | US5849943A (de) |
EP (1) | EP0788476B1 (de) |
JP (1) | JPH10507765A (de) |
AT (1) | ATE185797T1 (de) |
AU (1) | AU688980B2 (de) |
CA (1) | CA2200462A1 (de) |
DE (1) | DE69512930T2 (de) |
ES (1) | ES2139959T3 (de) |
WO (1) | WO1996013483A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9602877D0 (en) * | 1996-02-13 | 1996-04-10 | Merck Frosst Canada Inc | 3,4-Diaryl-2-hydroxy-2,5- dihydrofurans as prodrugs to cox-2 inhibitors |
DE69618820T2 (de) * | 1995-10-30 | 2002-06-20 | Merck Frosst Canada Inc | 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren |
FR2754256B1 (fr) * | 1996-10-08 | 1998-12-24 | Union Pharma Scient Appl | Nouveaux derives 1,2-diarylmethylenes, leurs procedes de preparation, et leurs utilisations en therapeutique |
FR2771005B1 (fr) * | 1997-11-18 | 2002-06-07 | Union Pharma Scient Appl | Nouvelle association pharmaceutique a activite analgesique |
US6649645B1 (en) | 1998-12-23 | 2003-11-18 | Pharmacia Corporation | Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia |
SK12672001A3 (sk) | 1999-12-08 | 2002-04-04 | Pharmacia Corporation | Zloženia inhibítora cyklooxygenázy-2 s rýchlym nástupom terapeutického účinku |
AP2002002582A0 (en) * | 1999-12-23 | 2002-09-30 | Nitromed Inc | Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
US7115565B2 (en) * | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
MY137736A (en) | 2001-04-03 | 2009-03-31 | Pharmacia Corp | Reconstitutable parenteral composition |
UA80682C2 (en) * | 2001-08-06 | 2007-10-25 | Pharmacia Corp | Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition |
AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
US7670769B2 (en) | 2002-05-09 | 2010-03-02 | The Brigham And Women's Hospital, Inc. | IL1RL-1 as a cardiovascular disease marker and therapeutic target |
ITMI20021391A1 (it) | 2002-06-25 | 2003-12-29 | Nicox Sa | Nitroderivati di inibitori della cicloossigenasi-2 |
JP2005535642A (ja) * | 2002-06-28 | 2005-11-24 | ニトロメッド インコーポレーティッド | オキシムおよび/またはヒドラゾンを含有するニトロソ化および/またはニトロシル化シクロオキシゲナーゼ−2選択的阻害剤、組成物、および使用方法 |
CA2493082A1 (en) * | 2002-07-26 | 2004-02-05 | Merck Frosst Canada & Co. | Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors |
AU2003261281A1 (en) | 2002-07-29 | 2004-02-16 | Nicox S.A. | Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
US6960611B2 (en) | 2002-09-16 | 2005-11-01 | Institute Of Materia Medica | Sulfonyl-containing 2,3-diarylindole compounds, methods for making same, and methods of use thereof |
AR043444A1 (es) * | 2003-03-05 | 2005-07-27 | Merck Frosst Canada Inc | Profarmacos de diaril-2- 5h -furanonas que liberan oxido nitrico como inhibidores de la ciclooxigenasa-2 |
WO2005077344A2 (en) | 2003-08-29 | 2005-08-25 | The Brigham And Women's Hospital, Inc. | Hydantoin derivatives as inhibitors of cellular necrosis |
US7781219B2 (en) | 2003-12-05 | 2010-08-24 | The Cleveland Clinic Foundation | Risk markers for cardiovascular disease |
EP2343553A1 (de) | 2004-10-06 | 2011-07-13 | The Brigham and Women's Hospital | Relevanz erzielter Niveaus von Markern für systemische Entzündung nach Behandlung |
WO2006044230A1 (en) * | 2004-10-12 | 2006-04-27 | Merck & Co., Inc. | Water soluble prodrugs of cox-2 inhibitors |
WO2006055404A2 (en) * | 2004-11-16 | 2006-05-26 | Merck & Co., Inc. | Compounds for targeting mechanisms implicated in the progression of stroke |
US20060189682A1 (en) * | 2005-02-02 | 2006-08-24 | Payne Joseph E | Water soluble prodrugs of COX-2 inhibitors |
US8119358B2 (en) | 2005-10-11 | 2012-02-21 | Tethys Bioscience, Inc. | Diabetes-related biomarkers and methods of use thereof |
EP2001496B1 (de) | 2006-03-15 | 2017-05-31 | The Brigham And Women's Hospital, Inc. | Verwendung von gelsolin zur diagnose und behandlung von entzündungserkrankungen |
EP2302395B1 (de) | 2006-06-07 | 2015-04-15 | Health Diagnostic Laboratory, Inc. | Mit arteriovaskulären Ereignissen assoziierte Marker und Verfahren zu ihrer Verwendung |
DK2147315T3 (da) | 2007-04-18 | 2013-09-23 | Tethys Bioscience Inc | Diabetesrelaterede biomarkører og fremgangsmåder til anvendelse deraf |
WO2008140251A2 (en) * | 2007-05-14 | 2008-11-20 | University-Industry Cooperation Group Of Kyung Hee University | Cyclooxygenase-2 inhibitors |
GB2462022B (en) | 2008-06-16 | 2011-05-25 | Biovascular Inc | Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof |
TW201201764A (en) | 2010-02-01 | 2012-01-16 | Hospital For Sick Children | Remote ischemic conditioning for treatment and prevention of restenosis |
WO2011121402A2 (en) | 2010-03-31 | 2011-10-06 | The Hospital For Sick Children | Use of remote ischemic conditioning to improve outcome after myocardial infarction |
WO2013170186A1 (en) | 2012-05-11 | 2013-11-14 | Reset Therapeutics, Inc. | Carbazole-containing sulfonamides as cryptochrome modulators |
JP2016514693A (ja) | 2013-03-15 | 2016-05-23 | プレジデント アンド フェローズ オブ ハーバード カレッジ | ハイブリッド型ネクロトーシス阻害剤 |
TWI690521B (zh) | 2014-04-07 | 2020-04-11 | 美商同步製藥公司 | 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類 |
EP3852732A1 (de) | 2018-09-19 | 2021-07-28 | ModernaTX, Inc. | Peg-lipide und deren verwendung |
JP2022500543A (ja) | 2018-09-19 | 2022-01-04 | モデルナティーエックス, インコーポレイテッド | 高純度peg脂質及びそれらの使用 |
CN113660934A (zh) | 2018-11-21 | 2021-11-16 | 特默罗制药股份有限公司 | 罗非昔布的纯化形式、制备方法和用途 |
US10945992B1 (en) | 2019-11-13 | 2021-03-16 | Tremeau Pharmaceuticals, Inc. | Dosage forms of rofecoxib and related methods |
WO2022195579A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases |
US11161833B1 (en) | 2021-04-09 | 2021-11-02 | Tremeau Pharmaceuticals, Inc. | Deuterated etoricoxib, methods of manufacture, and use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0424541A4 (en) * | 1989-04-24 | 1991-09-25 | Otsuka Pharmaceutical Factory, Inc. | 3-halogeno-2,3-diphenylacrylaldehyde derivative, method of production thereof and curing agent for hyperlipidemia |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5344991A (en) * | 1993-10-29 | 1994-09-06 | G.D. Searle & Co. | 1,2 diarylcyclopentenyl compounds for the treatment of inflammation |
US5393790A (en) * | 1994-02-10 | 1995-02-28 | G.D. Searle & Co. | Substituted spiro compounds for the treatment of inflammation |
-
1995
- 1995-10-24 ES ES95944787T patent/ES2139959T3/es not_active Expired - Lifetime
- 1995-10-24 DE DE69512930T patent/DE69512930T2/de not_active Expired - Fee Related
- 1995-10-24 WO PCT/CA1995/000601 patent/WO1996013483A1/en active IP Right Grant
- 1995-10-24 AU AU36950/95A patent/AU688980B2/en not_active Ceased
- 1995-10-24 JP JP8514204A patent/JPH10507765A/ja active Pending
- 1995-10-24 US US08/817,128 patent/US5849943A/en not_active Expired - Fee Related
- 1995-10-24 AT AT95944787T patent/ATE185797T1/de active
- 1995-10-24 CA CA002200462A patent/CA2200462A1/en not_active Abandoned
- 1995-10-24 EP EP95944787A patent/EP0788476B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2200462A1 (en) | 1996-05-09 |
ES2139959T3 (es) | 2000-02-16 |
US5849943A (en) | 1998-12-15 |
WO1996013483A1 (en) | 1996-05-09 |
AU688980B2 (en) | 1998-03-19 |
JPH10507765A (ja) | 1998-07-28 |
EP0788476B1 (de) | 1999-10-20 |
DE69512930D1 (de) | 1999-11-25 |
EP0788476A1 (de) | 1997-08-13 |
DE69512930T2 (de) | 2000-05-18 |
AU3695095A (en) | 1996-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE185797T1 (de) | Stilben-derivate verwendbar als cyclooxygenase-2 hemmer | |
NO971766D0 (no) | Anvendelsen av dioksomorfoliner for bekjempning av endoparasitter, nye dioksomorfoliner samt deres fremstilling | |
NL300175I2 (nl) | Methylsulfonylfenyl-2-(5H)-furanonen als remmers van COX-2. | |
ATE212343T1 (de) | 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren | |
EA200401471A1 (ru) | Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов | |
DK0772610T3 (da) | Dihydrobenzofuraner | |
DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
ES2092113T3 (es) | Derivados fluoroalcoxibencilamino de heterociclos que contienen nitrogeno. | |
ATE165825T1 (de) | Phenyl heterocyclen als cyclooxygenase-2 inhibitoren | |
BR9809185A (pt) | Diidropiranos fundidos | |
ATE192152T1 (de) | Piperidinderivate mit paf antagonistischer wirkung | |
BR9607240A (pt) | Derivados de fenila trissubstituidos | |
ATE316962T1 (de) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
DE69719358D1 (de) | Substituierte dihydrobenzofurane als pde-hemmstoffe | |
BR9509970A (pt) | Composto | |
ATE223376T1 (de) | Bisarylcyclobutenderivate als cyclooxygenasehemmer | |
ES2147973T3 (es) | Estirenos alquilatados como profarmacos de inhibidores de cox-2. | |
FI962323A0 (fi) | N-substituoidut atsabisykloheptaanijohdannaiset, kuten esim. neuroleptit | |
DE69703791T2 (de) | Diphenylstibene als prodrugs zu cox-2-inhibitoren | |
ES2156212T3 (es) | Derivados de azabicicloheptano n-substituidos como neurolepticos, etc. |